# Vertexynbio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vertexynbio

- Industry: Biotechnology
- Headquarters: Xuzhou, China
- Website: vertexynbio.cn
- Latest round: Series B (Nov 10, 2025)
- Investors on record: 1

## About

Founded in 2021 and based in Xuzhou, China, Vertexyn (Xuzhou) Bioworks Co., Ltd., trading as Vertexynbio, focuses on engineering biotechnology and biomanufacturing. The company has since expanded its portfolio to cover multiple fields, including pharmaceutical raw materials, natural cosmetic ingredients, functional foods, and bio-based colorants, integrating research and commercialization. In November 2025, Vertexynbio closed Series B funding from returning investor GF Xinde Investment.

The company develops and manufactures bio-based raw materials through synthetic biology and biomanufacturing technologies. Its portfolio spans pharmaceutical intermediates, natural ingredients for daily-use chemical products, functional food additives, and novel bio-based pigments. These products are positioned to meet demand in the healthcare, nutrition, agriculture, and consumer goods sectors.

The company generates revenue from the sales of bio-based raw materials and ingredients across pharmaceuticals, personal care, food, nutrition, and agriculture, supported by its research-driven product development and manufacturing operations.

## Funding rounds

- Series B, Nov 10, 2025 — GF Xinde Investment

## Investors

- GF Xinde Investment (https://capitalatlas.ai/funds/gf-xinde-investment) — Series B